Triple inhaled therapy aids in moderate-to-very severe COPD
(HealthDay)—Triple therapy, including glucocorticoid at either of two dose levels, is beneficial for moderate-to-very severe chronic obstructive pulmonary disease (COPD), according to a study published online June 24 in ...